OWLT — what changed in the latest 10-Q
A section-by-section comparison of OWLT's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-05-11 vs the prior 10-Q · 2025-11-13
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +31 | −68 | ~11 | 13 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Controls & procedures | Text added/removed | +3 | −10 | ~3 | 10 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
| Other information | Text added/removed | +3 | −1 | 0 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-05-11
Owlet is a leading pediatric health platform and the only company globally to offer U.S. FDA-cleared and internationally medically-certified wearable pediatric monitors for home use. Owlet's pediatric products and innovative software combine clinically tested monitoring systems, an integrated video …
We recognize revenue primarily from products and the associated mobile applications. Revenue is recognized when control of goods and services is transferred to customers in an amount that reflects the consideration expected to be received by us in exchange for those goods and services. A growing min…
Net income (loss) and comprehensive income (loss)$(3,336)$3,025
Allocation of accretion on convertible preferred stock to redeemable common stock11 —
Allocation of net income to participating securities to redeemable common stockholders— 14
Text removed vs the prior filing · source: 10-Q · 2025-11-13
Our mission is to empower parents with the right information at the right time, to give them more peace of mind and help them find more joy in the journey of parenting. Our digital parenting platform aims to give parents real-time data and insights to help parents feel calmer and more confident. We …
We recognize revenue primarily from products and the associated mobile applications. Revenues are recognized when control of goods and services is transferred to customers in an amount that reflects the consideration expected to be received by us in exchange for those goods and services. Substantial…
Three Months Ended September 30,Nine Months Ended September 30,
Allocation of net income to participating securities(499)— — —
Allocation of accretion on convertible preferred stock to redeemable common stock28 14 88 17
Controls & procedures
Text added vs the prior filing · source: 10-Q · 2026-05-11
We believe we have designed and implemented the internal controls necessary to remediate the material weakness related to debt and equity arrangements, including convertible preferred stock, warrant arrangements, and stock-based compensation modifications, as well as the material weakness related to…
We believe we have designed and implemented the internal controls necessary to remediate the material weakness related to IT general controls for information systems that are relevant to the preparation of our consolidated financial statements, including internal controls over the segregation of dut…
The material weaknesses will not be considered remediated until our remediation plan has been completed, the applicable controls operate for a sufficient period of time, and we have concluded, through testing, that the newly implemented and enhanced controls are operating effectively. As we continue…
Text removed vs the prior filing · source: 10-Q · 2025-11-13
Remediation of a Previously Reported Material Weakness in Internal Control Over Financial Reporting
As previously reported in our Form 10-Q for the period ending June 30, 2025, we identified material weaknesses in our internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a re…
•We did not design and maintain effective controls to verify the completeness and accuracy of sales returns.
In response to this identified material weakness, our management, with the oversight of the Audit Committee of our board of directors, has been actively engaged in remediating the above material weakness. During the year ended December 31, 2024 and the nine months ended September 30, 2025, we implem…
•A monthly review of accrued sales returns for appropriate valuation based on historical sales and return rates, and to ensure that estimated returns are appropriately reflected in revenue.
Other information
Text added vs the prior filing · source: 10-Q · 2026-05-11
Our Board of Directors has set the date of the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”) for July 10, 2026. The exact time and place of the 2026 Annual Meeting will be specified in our Notice of 2026 Annual Meeting and related proxy statement for the 2026 Annual Meeti…
Because the date of the 2026 Annual Meeting has been changed by more than 30 days from the first anniversary of our 2025 Annual Meeting of Stockholders, the Board has set a new deadline for the receipt of any stockholder proposals submitted for the 2026 Annual Meeting. If a stockholder desires to pr…
(c) During the three months ended March 31, 2026, no directors or “officers” (as defined in Rule 16a-1(f) under the Exchange Act) of the Company adopted, modified or terminated “Rule 10b5-1 trading arrangements” and/or “non-Rule 10b5-1 trading arrangements,” each as defined in Item 408 of Regulation…
Text removed vs the prior filing · source: 10-Q · 2025-11-13
(c) During the three months ended September 30, 2025, no directors or “officers” (as defined in Rule 16a-1(f) under the Exchange Act) of the Company adopted, modified or terminated “Rule 10b5-1 trading arrangements” and/or “non-Rule 10b5-1 trading arrangements,” each as defined in Item 408 of Regula…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice